Medical Malpractice Allegations of Iatrogenic Addiction in Chronic Opioid Analgesic Therapy: Forensic Case Reports

Pain Medicine

Volumn 11, Issue 10, 2010, Pages 1537-1545

  Fishbain, David A ^a,b,c,d   Lewis, John E ^a   Gao, Jinrun ^e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Douglas Gardens   (United States)

^c Douglas Gardens   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e State Farm Insurance   (United States)

Author keywords

Aberrant Drug Related behaviors; Addiction; Breaches of standards; Chronic opioid analgesic therapy; Chronic pain; Iatrogenic addiction; Intractable pain; Medical malpractice pllegations; Opioids; Re addiction; Standards of medical care

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; DIAZEPAM; DOXEPIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; METHADONE; METHAMPHETAMINE; NORDAZEPAM;

ADULT; ALCOHOLISM; ANALGESIA; ARTICLE; CASE REPORT; DRUG DEPENDENCE; DRUG OVERDOSE; FEMALE; FORENSIC SCIENCE; HUMAN; INFORMED CONSENT; MALE; MALPRACTICE; MEDICAL DOCUMENTATION; MEDICAL EXPERT; MEDICOLEGAL ASPECT; MONITORING; PAIN; PATIENT COMPLIANCE; PHYSICIAN; RISK FACTOR; TRIGGER POINT;

EID: 77956507787     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00938.x     Document Type: Article

References (61)

1. Fishbain DA. Chronic pain and addiction. Werner's Pain Management. A Practical Guide for Clinicians 2006, 117-39. Boswell MVCole BE. In, eds., 7th, edition, Boca Raton FL, CRS, Taylor and Francis, Chapter 10
2. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Steele-Rosomoff R. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008, 9(4):444-59.
3. Collins ED, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts. Am J Addict 2003, 12:93-100.
4. Shapiro RS. Health care providers' liability exposure for inappropriate pain management. J Law, Med Ethics 1996, 24:360-4.
5. Fitzgibbon DR, Rathmell JP, Michna E, Stephens LS, Posner KL, Domino KB. Malpractice claims associated with medication-management for chronic pain. Anesthesiology 2010, 112(4):948-56.
6. Fishbain DA, Cutler RB, Cole B. Medico-legal rounds: Medico-legal issues and alleged breaches of " standards of medical care" in opioid rotation to methadone: A case report. Pain Med 2003, 4(2):195-201.
7. Fishbain DA. Medico-legal rounds: Medico-legal issues and alleged breaches of " standards of medical care" in opioid tapering for alleged opioid addiction. Pain Med 2002, 3(2):135-42.
8. Fishbain DA, Lewis J, Cole B, Rosomoff RS, Rosomoff HL. Medico-legal rounds: Medico-legal issues and alleged breaches of " standards of medical care" in a patient motor vehicle accident, allegedly related to chronic opioid analgesic therapy; case report. J Opioid Manag 2007, 3(1):16-20.
9. Fishbain DA, Lewis J, Cole B, Rosomoff RS, Rosomoff HL. Alleged breaches of " standards of medical care" in a patient overdose death allegedly related to chronic opioid analgesic therapy: Case report. Application of the Controlled Substance Model Guidelines: Case Report. Pain Med 2009, 10(3):565-72.
10. Fishbain DA, Lewis J, Gao J, Cole B, Steele-Rosomoff R. Alleged patient abandonment in chronic opioid analgesic therapy: Case report. Pain Med 2009, 10(4):722-9.
11. Fishbain DA, Lewis J, Gao J, Cole B, Steele-Rosomoff R. Allegations of medical malpractice in chronic opioid analgesic therapy possibly related to collaborative/split treatment and the P-450 enzyme system: Forensic case report. Pain Med in press
12. Starfield B. Is US health really the best in the world? JAMA 2000, 284(4):483-5.
13. 109th Congress (2nd Session) Office of National Drug Control Policy Reauthorization Act of 2006. Public Law 109-469 Sec. 1106. Study on Iatrogenic Addiction Associated with Prescription Opioid Analgesic Drugs
14. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients. Preliminary validation of the opioid risk tool. Pain Med 2005, 6:432-42.
15. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: Evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 2003, 4:186-9.
16. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984, 252:1905-7.
17. Brown RI, Rounds LA. Conjoint screening questionnaire for alcohol and drug abuse Wisc. Med J 1995, 94:135-40.
18. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. Audit: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care http://en.wikipedia.org/wiki/Alcohol_Use_Disorders_Identification_Test, 7th, edition, New York, World Health Organization, Available at: (accessed July 29, 2010
19. Passik SD, Kirsh KL, McDonald MV. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage 2000, 19:274-86.
20. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders. Br J Addict 1989, 84:301-7.
21. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004, 112:65-75.
22. First MB, Spitzer RL, Gibbon JBW. Structured Clinical Interview for DSM-4 Axis 1 Disorders -Clinician Version 2005, Washington, DC, American Psychiatric Press, Inc
23. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, 4th, edition (DSM IV, Washington DC, American Psychiatric Association
24. Gutheil TG, Appelbaum PS. Clinical Handbook of Psychiatry and the Law 1991, 2nd, edition, Baltimore, MD, Williams & Wilkins
25. Model Guidelines for The Use of Controlled Substances for the Treatment of Pain. 1998, Federation State Medical Boards of the United States, Inc
26. Model policy for the use of controlled substances for the treatment of pain. 2004, http://www.fsmb.org/grpolpolicydocs.html, Federation of State Medical Boards of the United States, Inc, Available at: (accessed July 26, 2010
27. Chou R, Fanciullo G, Find PG. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10(2):113-30.
28. 1914, Schloendorff, V. Society of New York Hosp., 105 N.E. 92 (N.Y
29. 1979, Meretsky v. Ellenby, 370 So. 2d 1222 (Fla. Ct. App
30. 1988, Arena v. Gingrich, 305 Or. 1, 748P. 2d 547
31. 1985, Jackson v. Julian 694 S.W. 2d 434 (Tex. Ct. App
32. 1984, Johnson v. McMurray, 461 So. 2d 775 (Ala
33. 1973, Trogun v. Fruchtman, 58 Wis. 2d 596, 207 N.W. 2d 297, 312-13
34. Gallub E. Assessing culpability in the law of torts: A Call for Judicial Scrutiny in Comparing " Culpable Conduct." 1987, New York's CPLR 1411, 37 Syracuse L. Rev. 1079; 1121-27
35. 1985, Precourt v. Frederick, 395 Mass. 689, 481 N.E. 2d 1144, 1148
36. 1990, Moore v. Regents of the Univ. of California, 51 Cal. 3d 120, 165, 793 P. 2d 479, 271 Cal. Rptr. 147, note 41
37. Fishman SM. The trilateral pain contract bridging the pain clinic and the primary care physician through the opioid contract. J Pain Symptom Manage 2002, 24:335-44.
38. The Use of Opioids for the Treatment of Chronic Pain: A Consensus Statement from the American Academy of Pain Medicine (AAPM) and the American Pain Society (APS) 1997, AAPM and APS, Glenview, IL, Author
39. Jacox A. Management of Cancer Pain, Clinical Practice Guideline #9. 1994, Agency for Health Care Policy & Research, Pub No. 94-0596, Mar
40. Chou R, Fanciullo GJ, Fine PG. Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009, 10(2):131-46.
41. Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008, 9(8):1098-106.
42. Ives TJ, Chelminski PR, Hammett-Stabler CA. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006, 6(46):1-10.
43. Michna E, Ross EL, Hynes WL. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004, 28(3):250-8.
44. Fishman SM, Wilsey B, Yang J. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage 2000, 20(4):293-307.
45. Rinaldi R, Steindler E, Wilford D. Clarification and standardization of substance abuse terminology. JAMA 1988, 259:557-62.
46. Cowan D. Problematic terminology for problematic drug use. J Opioid Manage 2006, 2(1):23-30.
47. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992, 8:77-85.
48. Höjsted J, Sjögren P. Addiction to opioids in chronic pain patients: A literature review. Eur J Pain 2007, 11:490-518.
49. Akbik H, Butler SF, Budman SH. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage 2006, 32:287-93.
50. Passik S, Kirsh K, Casper D. Addiction-related tools and pain management: Instruments for screening, treatment planning, and monitoring compliance. Pain Med 2008, 9(S2):S145-66.
51. 1948, King v Solomon, 323 Mass. 326; 81 NE 2d 838; 8 AL 2D1
52. 1954, Los Alamos Medical Center v Coe 58 NM 686; 275 P 2d 175; 50 ALR 2d 1033
53. 1959, Rosenfeld v Coleman 19 Pa D and C 2d 635
54. 1983, McCarroll v Reed 679 P 2d 851
55. 1989, Adams v Allen 783 P 2d 635
56. 1978, Ballenger v Crowell, 38 N.C. App. 50, 247 S.E. 2d 287
57. 1997, Christine Rowan Kennedy v Dr. Steinberg (unreported), Court of Session, Outer House, Lord Marnoch
58. 2010, Webster's New World Law Dictionary. Wiley Pub. Inc. Hoboken J.J
59. 1995, Orzel v Scott Drug Co., 449 Mich. 550, 559-60; 537 NW 2d 208
60. 2006, Price v Purdue Pharma Co., 920 So. 2d 479, 484 (Miss
61. 2003, Folster v Purdue Pharma, L.P., 295. Supp. 2d 693, 705 (E.D. Ky